Jacqui Rowbottom
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 14
- HER2/EGFR in Cancer Research 6
- PARP inhibition in cancer therapy 4
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 3
-
- Lung Cancer Treatments and Mutations 7
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Peter Vuylsteke (2 shared papers)Ron H.J. Mathijssen (2 shared papers)Helen Mackay (2 shared papers)Amit M. Oza (2 shared papers)Barbara Schmalfeldt (2 shared papers)Gabe S. Sonke (2 shared papers)Marie Plante (2 shared papers)Michael Friedländer (2 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Clinical Cancer Research (1 paper)Annals of Oncology (1 paper)Lung Cancer (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Jacqui Rowbottom
13 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 1.2k
- Reproductive Medicine 271
- Pulmonary and Respiratory Medicine 791
- Cancer Research 321
- Molecular Biology 567
Countries citing papers authored by Jacqui Rowbottom
This map shows the geographic impact of Jacqui Rowbottom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqui Rowbottom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqui Rowbottom more than expected).
Fields of papers citing papers by Jacqui Rowbottom
This network shows the impact of papers produced by Jacqui Rowbottom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqui Rowbottom. The network helps show where Jacqui Rowbottom may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacqui Rowbottom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial Hit paper breakdown → | 2014 | 426 |
| 2 | Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial Hit paper breakdown → | 2016 | 384 |
| 3 | 2011 | 244 | |
| 4 | 2015 | 219 | |
| 5 | 2005 | 155 | |
| 6 | 2009 | 64 | |
| 7 | 2012 | 47 | |
| 8 | 2005 | 36 | |
| 9 | 2013 | 31 | |
| 10 | 2005 | 22 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2009 | 1 |
About Jacqui Rowbottom
Jacqui Rowbottom is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine, Molecular Biology and Surgery, having authored 14 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), HER2/EGFR in Cancer Research (6 papers), PARP inhibition in cancer therapy (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Gastric Cancer Management and Outcomes (2 papers) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Oncology (1.2k citations), Reproductive Medicine (271 citations), Pulmonary and Respiratory Medicine (791 citations), Cancer Research (321 citations) and Molecular Biology (567 citations). Jacqui Rowbottom has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Peter Vuylsteke, Ron H.J. Mathijssen, Helen Mackay, Amit M. Oza, Barbara Schmalfeldt, Gabe S. Sonke, Marie Plante, Michael Friedländer, Christopher Poole and Sven Mahner. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.